Evidence map›Paper›PMID 32666847›Full record

ArticleJournal of investigative medicine high impact case reports

Endoscopic Submucosal Tunnel Dissection as a Novel Therapeutic Technique in Patients With Barrett's Esophagus.

Faisal Inayat, Simcha Weissman, Adnan Malik, Badria Munir, Shahzad Iqbal

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Faisal InayatAllama Iqbal Medical College, Lahore, Punjab, Pakistan.ORCID 0000-0001-7576-7319
Simcha WeissmanHackensack University-Palisades Medical Center, North Bergen, NJ, USA.
Adnan MalikLoyola University Medical Center, Maywood, IL, USA.
Badria MunirAllama Iqbal Medical College, Lahore, Punjab, Pakistan.
Shahzad IqbalDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Allama Iqbal Medical College · PKDonald & Barbara Zucker School of Medicine at Hofstra/Northwell · USHackensack University Medical Center · USLoyola University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the ameliorated resectability prowess of endoscopic techniques, a myriad of diseases previously treated by major ablative surgeries are now endoscopically curable. Endoscopic submucosal tunnel dissection (ESTD) is a relatively new technique that has diversified endoscopic application. Although ESTD has frequently been used for the resection of esophageal neoplastic lesions, the clinical evidence pertaining to its efficacy in the treatment of circumferential Barrett's esophagus remains sparse. In this study, we evaluated ESTD as a potential therapeutic technique in patients with Barrett's esophagus-related high-grade dysplasia. The tunneling strategy helped achieve complete en bloc resection at an increased dissection speed, without any procedural complications. This article illustrates that ESTD can be a feasible, safe, and effective treatment for dysplastic Barrett's esophagus. Future research should aim to stratify the potential risks and complications associated with this optimization of endoscopic submucosal dissection in patients with superficial esophageal lesions.

Indexed as

Aged, 80 and overBarrett EsophagusEndoscopic Mucosal ResectionEsophageal NeoplasmsEsophagoscopyHumansMaleTreatment OutcomeBarrett’s esophaguscircumferential esophageal lesionsclinical outcomesendoscopic submucosal tunnel dissectionfeasibilityhigh-grade dysplasiasafetytherapeutic endoscopy

Identifiers

PMID32666847
PMCPMC7430079
OpenAlexW3043367602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.